Live Breaking News & Updates on Livija Deban

Stay updated with breaking news from Livija deban. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent for Immunotherapy Prime in Combination with Cell Therapies

Prokarium Ltd ('Prokarium' or the 'Company'), a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the receipt of a Notice of Allowance from the United ....

United States , United Kingdom , City Of , Kristen Albright , Kostenloser Wertpapierhandel , Lisa Stone , Livija Deban , Trademark Office , Prokarium Ltd , United States Patent , Chief Scientific Officer , Chief Executive Officer ,

Prokarium Exercises Option for an Exclusive Worldwide License for the Use of Salmonella Immunotherapy in the Treatment of Bladder Cancer

Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, announced today it exercised its option with Lausanne University Hospital (Centre Hospitalier Universitaire ....

United Kingdom , City Of , Patrice Jichlinski , Ilaria Lucca , Matthew Corcoran , Livija Deban , Kristen Albright , Kostenloser Wertpapierhandel , Denise Nardelli Haefliger , Sonia Domingos Pereira , Medicine Of The University Lausanne , Head Of The Urology Research Unit , Swiss Federal Institute Of Technology , Lausanne University Hospital Centre Hospitalier Universitaire Vaudois , Department Of Urology , Lausanne University Hospital , Centre Hospitalier Universitaire Vaudois , Chief Scientific Officer , Urology Research , Prof Patrice Jichlinski , Prof Beat Roth , Non Muscle Invasive Bladder Cancer , Bacillus Calmette Gu , Swiss Federal Institute , Executive Officer , Dougall Advisors ,

Prokarium Promotes Livija Deban to Chief Scientific Officer to Drive Pipeline Expansion in Cancer Immunotherapy

Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Livija Deban, PhD, as Chief Scientific Officer. This press release ....

United Kingdom , City Of , Kristen Albright , Mario Brkulj , Oxford Biotherapeutics , Kostenloser Wertpapierhandel , Livija Deban , King College London , University Vita , Cancer Research United Kingdom , University Of Bologna , Chief Scientific , Chief Scientific Officer , Business Wire , Chief Executive Officer , Vice President , Medical Biotechnology , Applied Immunology , University Vita Salute San Raffaele , Executive Officer ,